CYLIOS Trademark

Trademark Overview


On Tuesday, August 3, 2021, a trademark application was filed for CYLIOS with the United States Patent and Trademark Office. The USPTO has given the CYLIOS trademark a serial number of 79319588. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, February 25, 2024. This trademark is owned by NOVARTIS AG. The CYLIOS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and biological preparations for the prevention or treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system, and the genitourinary system, and for the treatment of inflammatory diseases and disorders; pharmaceutical and biological preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treatment of gastroenterological diseases and disorders; pharmaceutical and biological preparations for the prevention and treatment of ocular disorders and diseases, for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; pharmaceutical and biological preparations, namely, anti-fungal, anti-infective, antiviral and antibiotic preparations
cylios

General Information


Serial Number79319588
Word MarkCYLIOS
Filing DateTuesday, August 3, 2021
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, February 25, 2024
Registration Number6641718
Registration DateTuesday, February 15, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 30, 2021

Trademark Statements


Goods and ServicesPharmaceutical and biological preparations for the prevention or treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system, and the genitourinary system, and for the treatment of inflammatory diseases and disorders; pharmaceutical and biological preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treatment of gastroenterological diseases and disorders; pharmaceutical and biological preparations for the prevention and treatment of ocular disorders and diseases, for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; pharmaceutical and biological preparations, namely, anti-fungal, anti-infective, antiviral and antibiotic preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateSunday, February 25, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH

Trademark Events


Event DateEvent Description
Tuesday, October 26, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 2, 2021SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Thursday, September 9, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Monday, September 13, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 17, 2021APPLICATION FILING RECEIPT MAILED
Tuesday, October 19, 2021ASSIGNED TO EXAMINER
Monday, November 8, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 17, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Monday, November 8, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 8, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, November 8, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, November 8, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 8, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 10, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 17, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, November 30, 2021PUBLISHED FOR OPPOSITION
Tuesday, November 30, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sunday, December 12, 2021NOTIFICATION PROCESSED BY IB
Tuesday, February 15, 2022REGISTERED-PRINCIPAL REGISTER
Monday, July 4, 2022NOTIFICATION PROCESSED BY IB
Tuesday, October 8, 2024DEATH OF INTERNATIONAL REGISTRATION
Tuesday, October 8, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Saturday, June 4, 2022FINAL DISPOSITION NOTICE SENT TO IB
Thursday, March 17, 2022GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Friday, June 3, 2022FINAL DISPOSITION PROCESSED